Dermatologicals in the United Arab Emirates

Dermatologicals in the United Arab Emirates
Hair loss treatments in the United Arab Emirates has been experiencing increased fragmentation, due to the emergence of numerous new entrants, with the value share of the smallest players, included under “others” set to rise above 50% for the first time in 2023. This influx of products and services has led to increased competition and a redistribution of share amongst existing and new players. The expanding options for consumers have diversified their choice, resulting in a fragmented landscape...

Euromonitor International's Dermatologicals in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.